
CAS 500863-50-3: Kevetrin
Description:Kevetrin, with the CAS number 500863-50-3, is a small molecule compound that has garnered attention in the field of cancer research. It is primarily known for its potential as an anti-cancer agent, particularly due to its ability to activate the p53 tumor suppressor pathway. The p53 protein plays a crucial role in regulating the cell cycle and preventing tumor formation, making Kevetrin a candidate for therapeutic applications in various malignancies. The compound is characterized by its unique chemical structure, which facilitates its interaction with cellular mechanisms involved in tumor suppression. In preclinical studies, Kevetrin has demonstrated the ability to induce apoptosis in cancer cells and inhibit tumor growth, highlighting its potential efficacy. Additionally, its pharmacological profile suggests a favorable safety margin, although further clinical trials are necessary to fully establish its therapeutic potential and safety in humans. Overall, Kevetrin represents a promising avenue for targeted cancer therapy, particularly in tumors with dysfunctional p53 pathways.
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | 4-Isothioureidobutyronitrile-13C2, 15N3 Hydrochloride REF: TR-I917507CAS: | - - - | 1,568.00 € | Wed 28 May 25 |
![]() | 2-(3-Cyanopropyl)isothiourea REF: 3D-AVA86350CAS: 500863-50-3 | Min. 95% | - - - | Discontinued product |

4-Isothioureidobutyronitrile-13C2, 15N3 Hydrochloride
Controlled ProductRef: TR-I917507
10mg | 1,568.00 € |

2-(3-Cyanopropyl)isothiourea
Ref: 3D-AVA86350
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information |